Logo-aim
Arch Iran Med. 2024;27(10): 573-579. doi: 10.34172/aim.31725
PMID: 39492564        PMCID: PMC11532653

Original Article

Endotracheal Surfactant and Budesonide Combination Therapy in Neonatal Acute Respiratory Distress Syndrome due to Late-Onset Sepsis

Asli Okbay Gunes 1 * ORCID, Aydin Bozkaya 1 ORCID

Cited by CrossRef: 0


1- Fatima U, Naveed N, Riaz Z, Khalid E, Qamer A, Baig S, Fatima R, Hussain A, Mustunsar Z, Khan A, Mangan S, Kumari M, Ali Qasim S, Hasan A, Ahmed R. Comparative Efficacy and Safety Profile of the Combination of Pulmonary Surfactant and Budesonide vs. Surfactant Alone in the Management of Neonatal Respiratory Distress Syndrome: An Updated Meta-Analysis. Medicina. 2025;61(8):1329 [Crossref]
2- Yu A, Hou H, Ran L, Sun X, Xin W, Feng T. A nomogram for predicting neonatal acute respiratory distress syndrome in patients with neonatal pneumonia after 34 weeks of gestation. Front Pediatr. 2025;12 [Crossref]


SCImago Journal & Country Rank

About Us

A Monthly Peer-Reviewed Medical Journal Published by the Academy of Medical Sciences of the I.R. Iran; Indexed in PubMed/MEDLINE, ISI Web of Science, EMBASE, SCOPUS, CINHAL, PASCAL, CSA, SID, ISSN: Print 1029-2977, Online 1735-3947.The impact factor of Archives of Iranian Medicine according to Journal Citation Reports® (JCR®) 2016 is 1.20.